SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,414,978 | +17.2% | 68,755 | +167.7% | 0.08% | +20.0% |
| Q2 2023 | $1,207,427 | -7.6% | 25,679 | -17.5% | 0.06% | -19.8% |
| Q1 2023 | $1,306,802 | +173.4% | 31,144 | +170.7% | 0.08% | +200.0% |
| Q2 2020 | $478,000 | +70.7% | 11,507 | +18.1% | 0.03% | +28.6% |
| Q1 2020 | $280,000 | -70.8% | 9,741 | -26.7% | 0.02% | -50.0% |
| Q4 2019 | $959,000 | -42.5% | 13,288 | +11.8% | 0.04% | -50.0% |
| Q3 2019 | $1,668,000 | -27.7% | 11,887 | -5.7% | 0.08% | -22.9% |
| Q2 2019 | $2,307,000 | +3.6% | 12,600 | -10.0% | 0.11% | +1.9% |
| Q1 2019 | $2,226,000 | +80.7% | 13,993 | +8.8% | 0.11% | +40.8% |
| Q4 2018 | $1,232,000 | -45.4% | 12,866 | -19.4% | 0.08% | -11.6% |
| Q3 2018 | $2,255,000 | – | 15,967 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |